Early-Stage

Groupe PARIMA supports early‑stage projects by building technical readiness for clinical manufacturing and scientifical decision‑making.

AdobeStock_1862304399 1
Early development support

Keeping pace with early development

Groupe PARIMA supports early-stage programs through product development, submission, and clinical lots manufacturing. We help small-molecule, non-sterile products move from laboratory scale into phase‑appropriate GMP production, with the documentation, methods, and controls required to support the next stages.

Guide early-stage with precision

We combine product development expertise, direct access to scientific teams, and operational flexibility to enable efficient early clinical execution.

Move into GMP with confidence

Phase‑appropriate GMP clinical manufacturing, supported by robust documentation, traceability, and operational discipline.

Build the right technical foundation

Establish development and method activities that generate reliable data and support early clinical manufacturing and regulatory expectations.

Plan the next steps With Efficiency

Address early‑stage development and clinical supply needs while establishing technical choices that support future progression.

One site, faster progression

Early‑stage programs require a CDMO that combines rapid execution with strong quality oversight. Groupe PARIMA’s one-site model connects scientific teams, in-house analytical support, and GMP manufacturing, helping you maintain continuity, strengthen early documentation, and reduce risks.

01
Card 01

Direct access to scientific teams

Work directly with formulation, analytical, and manufacturing experts to support development activities, technical decision‑making, and preparation for clinical lots and submission.

02
Card 02

Integrated analytical support

In‑house analytical development and testing generate reliable data to support R&D activities, clinical batch release, and submission‑ready documentation at an early stage.

03
Card 03

Flexibility for early-stage reality

Our operations adapt to small‑scale batches and evolving early‑stage requirements, supporting R&D activities and clinical lot manufacturing as programs mature toward submission.

04
Card 04

Practical early-stage progression

We support development and early clinical manufacturing while building documentation, methods, and packaging that facilitate regulatory submission and next‑stage advancement.

Our Services

We take a flexible, phase‑appropriate approach that supports R&D activities, GMP clinical manufacturing, and the technical documentation required for early submissions.

01
Layer_1-1
Product Development

Support formulation and process decisions suited to early clinical manufacturing.

02
Icons-1
Analytical Services

Provide the method and testing support needed to guide Phase I execution.

03
Icons (1)-1
Manufacturing & Packaging

Adjust batch size and packaging format to meet Phase I requirements, with the flexibility early programs need.

We take a practical approach to early stage, supporting development and clinical lots with the right level of technical rigor.

Resources

Explore resources that clarify early‑stage development and clinical lot requirements, to the practical steps that prepare projects for regulatory submission.

Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development
Groupe PARIMA
2026/04/27
How Drug Product Formulation Works: Topical, Oral, and Nasal Liquid and Semi-Solid Dosage Forms
Groupe PARIMA
2026/03/18
How Early API Characterization Can Reduce Formulation and Scale-up Risks
Groupe PARIMA
2025/10/23
Topical 101: A Guide to Complex Dermatology Formulation Development

Contact us

Discuss your early-stage project

Tell us where your product stands, and our team can help you define the next development and clinical steps.